Health Care & Life Sciences » Pharmaceuticals | Coral Laboratories Ltd.

Coral Laboratories Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
67
66
89
123
114
Total Accounts Receivable
198
303
361
366
410
Inventories
83
105
135
209
176
Other Current Assets
27
28
61
168
25
Total Current Assets
375
503
646
867
723
Net Property, Plant & Equipment
197
189
180
184
212
Total Investments and Advances
24
25
60
139
461
Long-Term Note Receivable
-
-
-
-
6
Intangible Assets
-
-
-
1
1
Other Assets
9
8
8
5
-
Total Assets
605
724
895
1,195
1,402
ST Debt & Current Portion LT Debt
2
14
4
22
17
Accounts Payable
51
63
97
100
128
Income Tax Payable
21
26
49
131
-
Other Current Liabilities
13
19
30
63
56
Total Current Liabilities
88
121
180
316
202
Provision for Risks & Charges
1
1
2
2
3
Deferred Taxes
8
9
10
30
32
Other Liabilities
2
2
2
2
2
Total Liabilities
99
133
193
351
239
Common Equity (Total)
506
591
702
845
1,163
Total Shareholders' Equity
506
591
702
845
1,163
Total Equity
506
591
702
845
1,163
Liabilities & Shareholders' Equity
605
724
895
1,195
1,402

About Coral Laboratories

View Profile
Address
3-B, Patanwala Compound
Mumbai Maharashtra 400086
India
Employees -
Website http://www.corallab.com
Updated 09/14/2018
Coral Laboratories Ltd. engages in the manufacture of pharmaceutical formulations. It operates through the following geographical segments: Ethopia, India, and Rest of World. Its products include tablets, capsules, liquids, topical preparations, eye and ear drops, and injectables.